TERIFLUNOMIDE for Relapsing multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 111 adverse event reports in the FDA FAERS database where TERIFLUNOMIDE was used for Relapsing multiple sclerosis.
Most Reported Side Effects for TERIFLUNOMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Alopecia | 5,441 | 13.9% | 28 | 611 |
| Multiple sclerosis relapse | 4,745 | 12.1% | 39 | 1,012 |
| Fatigue | 4,257 | 10.8% | 39 | 692 |
| Diarrhoea | 4,175 | 10.6% | 46 | 680 |
| Fall | 2,878 | 7.3% | 41 | 771 |
| Hypoaesthesia | 2,851 | 7.3% | 24 | 540 |
| Headache | 2,651 | 6.8% | 24 | 435 |
| Paraesthesia | 2,472 | 6.3% | 19 | 416 |
| Drug ineffective | 2,469 | 6.3% | 16 | 250 |
| Nausea | 2,311 | 5.9% | 34 | 464 |
| Gait disturbance | 2,074 | 5.3% | 27 | 572 |
| Pain | 1,985 | 5.1% | 21 | 467 |
| Multiple sclerosis | 1,983 | 5.1% | 24 | 337 |
| Condition aggravated | 1,796 | 4.6% | 20 | 392 |
| Depression | 1,612 | 4.1% | 18 | 283 |
Other Indications for TERIFLUNOMIDE
Multiple sclerosis (29,963)
Product used for unknown indication (1,438)
Relapsing-remitting multiple sclerosis (1,320)
Multiple sclerosis relapse (216)
Illness (153)
Secondary progressive multiple sclerosis (37)
Demyelination (19)
Rheumatoid arthritis (19)
Migraine (18)
Ill-defined disorder (17)
Other Drugs Used for Relapsing multiple sclerosis
OCRELIZUMAB (6,883)
OFATUMUMAB (3,705)
FINGOLIMOD (851)
GLATIRAMER (375)
ALEMTUZUMAB (350)
SIPONIMOD (194)
INTERFERON BETA-1A (192)
NATALIZUMAB (140)
RITUXIMAB (136)
OZANIMOD (127)